Browsing by Author "Chatterjee, Chirantan"
Now showing items 1-20 of 43
-
Balancing affordability and availability in a drug patent regime
Pingali, Viswanath; Chatterjee, Chirantan (Economic and Political Weekly, 2015)India needs to fi nd an optimal patenting regime that will safeguard incentives for innovation while simultaneously ensuring that medicines are available at reasonable prices. -
A blot on mother's day
Chatterjee, Chirantan (DNA India, 2019-05-12) -
COILPAY: India market analysis
Tajbije, Abhishek; Singh, Arpit (Indian Institute of Management Ahmedabad, 2020)CoilPay Technologies Inc. (Coil) is a fintech start-up aiming to disrupt the existing payment behavior by introducing a wearable contactless payments device that combines the features of a smartwatch with NFC technology ... -
Competition law in india: perspectives
Pingali, Viswanath; Chaudhuri, Manas Kumar; Malik, Payal; Tamara, Ram; Kakkar, Avaantika; Chatterjee, Chirantan; Mondal, Shamim; Sokol, D Daniel (Sage, 2016)In 2002, the Parliament of India enacted the Competition Act, replacing the archaic Monopoly and Restrictive Trade Practices Act (popularly referred to as the MRTP Act) of 1969. The primary goal of the Act, as stated in ... -
Comprehensive study on electric vehicles strategy for the Indian market
P., Gouthaman; Agrawal, Nishant P. (Indian Institute of Management Ahmedabad, 2020)Electric vehicles are the need of the hour with environmental pollution levels at an all-time high. Various measures are being taken to curb air pollution. Pollution from vehicles forms a major chunk of this and it is high ... -
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
Pingali, Viswanath; Chatterjee, Chirantan; Kubo, Kensuke (Elsevier, 2015)This paper empirically examines the consumer welfare implications of changes in government policies related to patent protection and compulsory licensing in the Indian market for oral anti-diabetic (OAD) medicines. In ... -
COVID-19 & science, narratives & mental wellness (WIP)
P., Vaishak (Indian Institute of Management Ahmedabad, 2020)A majority of the current generation has not seen a pandemic in full force. The COVID-19 has disrupted the world over in ways never seen before. Healthcare systems, supply chain and whole economies have been disrupted the ... -
Crocin or paracetamol: what should the doctor prescribe?
Chatterjee, Chirantan; Kensuke, Kubo; Pingali, Viswanath (Economic & Political Weekly, 2013)As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes ... -
Cross-border environmental regulation and firm labor demand
Chakraborty, Pavel; Chakrabarti, Anindya S.; Chatterjee, Chirantan (Elsevier, 2022-11-07)In 1994, due to environmental concerns, Germany banned a chemical called ‘Azo-dyes’, a primary input for the leather and textiles firms in India (a key exporter). Exploiting this as a quasi-natural experiment, we examine ... -
Did COVID-19 lockdown impact consumption of risky fairness creams in India?
Kumar, Abhay; Singhania, Ankita (Indian Institute of Management Ahmedabad, 2020)Fairness industry, all over the globe is going through a drastic change in its structure. The outrage against the killing of George Floyd’s in America led to multiple accusations against the fairness industry like openly ... -
Did India’s price control policy for coronary stents create unintended consequences?
Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar (Social Science & Medicine, 2020)In February 2017, India capped the retail price of coronary stents and restricted the channel margin to bring Percutaneous Transluminal Coronary Angioplasty (PTCA) procedure, which uses coronary stents, within reach of ... -
Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data
Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan (Elsevier, 2024-01-01)It is now much discussed that Artificial Intelligence (AI) as a General-Purpose Technology (GPT) can resolve the efficiency problems of industries, including in pharmaceutical markets where productivity challenges continue ... -
Fake news and misinformation
Shingi, Rashish Rajendra; Bhageria, Srishti (Indian Institute of Management Ahmedabad, 2020)Social media and internet have highly disrupted the ways in which we consume Information. This has led to dilution of journalism standards on such platforms which brings with it the problems of fake news and information ... -
Flattening the curve: COVID-19 & grand challenges for global health, innovation, and economy
Chatterjee, Chirantan; Chakrabarti, Anindya S; Deolalikar, Anil B (World Scientific, 2023)One of the key issues the world grappled with during COVID-19 was the distributional implications of lockdowns globally. The shadow of lockdown policies continues when nations still try to emerge out of the pandemic. ... -
From courts to markets: new evidence on enforcement of pharmaceutical bans in India
Chatterjee, Chirantan; Mohapatra, D. P.; Estay, M. (Social Science & Medicine, 2019)Regulatory enforcement of product safety standards given health concerns, whether it is in romaine lettuce, smartphones or cars, is emerging to be a challenge for global public health. This is particularly true for developing ... -
Future of sports and politics: historically, popular leaders have used sports to gain the legitimacy they desperately need
Chatterjee, Chirantan (DNA India, 2019-07-08) -
Generic competition and the incentives for early-stage pharmaceutical innovation
Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. (Elsevier, 2022-12-01)What impact has rising generic competition had on the nature and direction of pharmaceutical innovation? We find broad-based, strong evidence that pharmaceutical companies have diverted their new drug development efforts ... -
How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic
Chatterjee, Chirantan; Adbi, Arzi; Mishra, Anant (PubsOnLine, 2022-03-23)Global shocks bring unanticipated changes in the business environment of foreign multinational enterprises (MNEs) and rival domestic firms. We examine whether there is a difference between how MNEs and domestic firms react ... -
How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry
Bhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico (INFORMS: Institute for Operations Research and the Management Sciences, 2021-02-09)We study coercive institutional pressures as an impetus for firms to reposition across intraindustry boundaries. Integrating the literatures on strategic repositioning and submarkets, we predict that firms respond to ... -
Impact of non pharmaceutical (demand side) and pharmaceutical (supply side) intervention on spread of Covid-19
Das, Manideepto; Metre, Sunita (Indian Institute of Management Ahmedabad, 2020)The pandemic of coronavirus disease (COVID-19), which originated in Wuhan, China, has spread rapidly to different countries, with several cases registered globally. As of January 8, 2021, more than 10 million positive cases ...